Onivyde Approved for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

The FDA approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals) with oxaliplatin, fluorouracil and ...

FEBRUARY 14, 2024